Published in Mol Diagn Ther on June 01, 2011
PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease. Int J Clin Exp Pathol (2015) 0.78
Association between T174M polymorphism in the angiotensinogen gene and risk of coronary artery disease: a meta-analysis. J Geriatr Cardiol (2013) 0.78
Angiotensin-converting enzyme gene polymorphisms and hypertension in occupational noise exposure in Egypt. Int J Occup Environ Health (2014) 0.77
Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic Diseases. PLoS One (2016) 0.75
Angiotensinogen-M235T as a risk factor for myocardial infarction in Asian populations: a genetic association study and a bioinformatics approach. Croat Med J (2016) 0.75
Influence of dynamic training on hemodynamic, neurohormonal responses to static exercise and on inflammatory markers in patients after coronary artery bypass grafting. Circ J (2010) 2.09
Trends in heart failure mortality in Poland between 1980 and 2010. Pol Arch Med Wewn (2013) 2.04
Is evaluation of complex polymorphism helpful in the assessment of prognosis after percutaneous coronary intervention. A prospective study. Kardiol Pol (2011) 2.03
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapical approach: 30-day follow-up of the initial 30 patients. Kardiol Pol (2011) 1.46
Impact of MTHFR C677T gene polymorphism and vitamins intake on homocysteine concentration in the Polish adult population. Kardiol Pol (2011) 1.44
Mortality from ischaemic heart disease in Poland in 1991-1996 estimated by the coding system used since 1997. Kardiol Pol (2010) 1.43
Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function? Kardiol Pol (2011) 1.41
Early implementation of continuous venovenous haemodiafiltration improves outcome in patients with heart failure complicated by acute kidney injury. Kardiol Pol (2011) 1.41
Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy. Kardiol Pol (2009) 1.41
[Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience]. Kardiol Pol (2012) 1.39
Knowledge about arterial hypertension in the Polish population: the WOBASZ study. Kardiol Pol (2012) 1.39
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J (2008) 1.19
A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail (2009) 1.07
Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study--WOBASZ. Pol Arch Med Wewn (2011) 1.02
Right heart perforation by pacemaker leads. Arch Med Sci (2012) 0.95
[Multicenter national Polish population health status tests--WOBASZ project. Establishment of methods and logistics]. Kardiol Pol (2005) 0.88
Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload. Eur J Heart Fail (2007) 0.87
Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome. Growth Factors (2010) 0.85
The relationship between resting heart rate and atherosclerosis risk factors. Kardiol Pol (2008) 0.85
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement]. Kardiol Pol (2011) 0.85
Multi-centre National Population Health Examination Survey (WOBASZ II study): assumptions, methods, and implementation. Kardiol Pol (2015) 0.85
Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine (2013) 0.84
The impact of early menopause on risk of coronary artery disease (PREmature Coronary Artery Disease In Women--PRECADIW case-control study). Eur J Prev Cardiol (2011) 0.84
Feasibility of home-based cardiac telerehabilitation: Results of TeleInterMed study. Cardiol J (2014) 0.82
Ten-year risk of fatal cardiovascular disease in the Polish population and medical care. Results of the WOBASZ study. Kardiol Pol (2010) 0.82
Transcatheter pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: early and mid-term results. J Invasive Cardiol (2015) 0.82
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur Heart J (2010) 0.82
Effect of protein convertase subtilisin/kexin type 9 (PCSK9) 46L gene polymorphism on LDL cholesterol concentration in a Polish adult population. Mol Genet Metab (2008) 0.81
Severe chronic heart failure in patients considered for heart transplantation in Poland. Cardiol J (2012) 0.80
[Optimal model of comprehensive rehabilitation and secondary prevention]. Kardiol Pol (2013) 0.80
Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Kardiol Pol (2008) 0.80
Characterization of insomnia in patients with essential hypertension. Blood Press (2006) 0.80
Is the decrease of cardiovascular mortality in Poland associated with the reduction of global cardiovascular risk related to changes in life style? Kardiol Pol (2003) 0.80
Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol (2011) 0.79
Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid. Acta Biochim Pol (2011) 0.79
Alterations in calcium regulatory protein expression in patients with preserved left ventricle systolic function and mitral valve stenosis. J Card Fail (2008) 0.78
[Awareness of guidelines for cardiovascular disease prevention among the adult population in Poland. Results of the WOBASZ program]. Kardiol Pol (2005) 0.78
Did favourable trends in food consumption observed in the 1984-2001 period contribute to the decrease in cardiovascular mortality? - Pol-MONICA Warsaw Project. Kardiol Pol (2006) 0.78
GROWTH RATE OF PARAGANGLIOMAS RELATED TOGERMLINE MUTATIONS OF THE SDHX GENES. Endocr Pract (2016) 0.77
Dilated cardiomyopathy with profound segmental wall motion abnormalities and ventricular arrhythmia caused by the R541C mutation in the LMNA gene. Int J Cardiol (2009) 0.77
Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography. Neuroendocrinology (2015) 0.77
Familial dilated cardiomyopathy: evidence for clinical and immunogenetic heterogeneity. Med Sci Monit (2003) 0.77
Quality of nutrition and health knowledge in subjects with diagnosed cardio-vascular diseases in the Polish population--National Multicentre Health Survey (WOBASZ). Kardiol Pol (2008) 0.77
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: a series of cases. Kardiol Pol (2015) 0.77
Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol (2011) 0.77
Tobacco smoking in Poland in the years from 2003 to 2014. Multi‑centre National Population Health Examination Survey (WOBASZ). Pol Arch Intern Med (2017) 0.77
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kardiol Pol (2003) 0.76
Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis. Med Sci Monit (2008) 0.76
Clustering of admission hyperglycemia, impaired renal function and anemia and its impact on in-hospital outcomes in patients with ST-elevation myocardial infarction. Atherosclerosis (2009) 0.76
[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol (2015) 0.76
Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn (2016) 0.75
Method of variability optimization in pharmacokinetic data analysis. Eur J Drug Metab Pharmacokinet (2013) 0.75
[Not Available]. Kardiol Pol (2012) 0.75
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland - authors' reply]. Kardiol Pol (2012) 0.75
Hepatocyte growth factor concentration during the first day of acute coronary syndrome. Arch Med Sci (2012) 0.75
Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. J Thromb Thrombolysis (2014) 0.75
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. Kardiol Pol (2013) 0.75
Coronary artery fistula in a 70 year-old woman with myocardial infarction. Kardiol Pol (2011) 0.75
The relevance of the age of transfused blood for prognosis after transcatheter aortic valve implantation (TAVI). Pol Arch Intern Med (2017) 0.75
[Addiction to tobacco smoking in the Polish population. Results of the WOBASZ program]. Kardiol Pol (2005) 0.75
QTc prolongation in patients with hearing loss: Electrocardiographic and genetic study. Cardiol J (2015) 0.75
Hepatocyte growth factor - the earliest marker of myocardial injury in ST-segment elevation myocardial infarction. Kardiol Pol (2013) 0.75
[The role of vitamins and minerals supplementation in nutrition of urban and rural population--Pol-MONICA Project]. Przegl Lek (2003) 0.75
Usefulness of 6-minute walk test, plasma neurohumoral and cytokine activation in the assessment of symptomatic patients with left ventricle dysfunction caused by chronic severe mitral valve regurgitation. Acta Cardiol (2010) 0.75
Heart failure patients from hospital settings in Poland: population characteristics and treatment patterns, a multicenter retrospective study. Cardiol J (2008) 0.75
Prognostic value of pulmonary hemodynamic parameters in cardiac transplant candidates. Cardiol J (2014) 0.75
Is the assessment of lipid profile performed up to seventy two hours from hospital admission due to acute coronary syndrome still valid? Kardiol Pol (2004) 0.75
[Socioeconomic factors and their differentiation in the Polish population. Results of the WOBASZ program]. Kardiol Pol (2005) 0.75
Determinants of the reduction in B-type natriuretic peptide after mitral valve replacement in patients with rheumatic mitral stenosis. Clin Physiol Funct Imaging (2010) 0.75
Brain natriuretic peptide plasma levels in ischemic and nonischemic advanced heart failure. Acta Cardiol (2004) 0.75
Influence of aerobic training on neurohormonal and hemodynamic responses to head-up tilt test and on autonomic nervous activity at rest and after exercise in patients after bypass surgery. Cardiol J (2013) 0.75
Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarction. Gene (2012) 0.75
Influence of some cardiovascular risk factors on the expression of platelet glycoprotein IIb/IIIa receptors in patients with myocardial infarction treated with antiplatelet drugs under primary percutaneous coronary intervention. Mol Diagn Ther (2009) 0.75
A severe complication after ST-segment elevation myocardial infarction (Part 1). Med Sci Monit (2011) 0.75
Endothelium-dependent acetylcholine-induced vasodilatory response of saphenous vein grafts. Kardiol Pol (2006) 0.75
Combined renin-angiotensin system gene polymorphisms and outcomes in coronary artery disease - a preliminary report. Kardiol Pol (2011) 0.75
[Conclusions from the meeting of the National Cardiology Supervision Team]. Kardiol Pol (2011) 0.75
Cardiovascular health knowledge of Polish population. Comparison of two National Multicenter Health Surveys WOBASZ and WOBASZ II. Kardiol Pol (2017) 0.75
A novel life-threatening mutation in long QT2 syndrome. Kardiol Pol (2015) 0.75
Correlations between no observed effect level and selected parameters of the chemical structure for veterinary drugs. Toxicol In Vitro (2010) 0.75
Novel markers of cerebral embolism in the course of infective endocarditis. Int J Cardiol (2011) 0.75
Relationship between 28-year food consumption trends and the 10-year global risk of death due to cardiovascular diseases in the adult Warsaw population. Kardiol Pol (2015) 0.75
Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone. Am J Cardiovasc Drugs (2007) 0.75
Impact of genetic and clinical factors on dose requirements and quality of anticoagulation therapy in Polish patients receiving acenocoumarol: dosing calculation algorithm. Pharmacogenet Genomics (2013) 0.75
[Are fluctuations in health status related to socioeconomic factors among the Polish population?]. Pol Arch Med Wewn (2003) 0.75
Qualitative structure residue relationship analysis in the determination of the maximum residue limit of veterinary drugs. Chemosphere (2012) 0.75
A severe complication after ST-segment elevation myocardial infarction (Part 2). Med Sci Monit (2011) 0.75
[Realization of guidelines for prevention of cardiovascular diseases by physicians POZ in the general population. Results of the WOBASZ program]. Kardiol Pol (2005) 0.75
Old markers, new approach to assessment of risk in heart failure. Kardiol Pol (2015) 0.75